患者招募_健趣网

#	项目名称	适应疾病	介入/药物	详情
434	Efficacy of STABLOR® on Visceral Fat Mass Reduction in Patients With Metabolic Syndrome	Metabolic Syndrome	Dietary Supplement:Stablor Dietary Supplement:placebo	详情
435	Pulmonary Rehabilitation in Functional Outcomes and Its Relationship With Morbidity and Mortality in Patients With COPD	Pulmonary Disease, Chronic Obstructive	Other:Pulmonary rehabilitation	详情
436	Careseng 1370 for Chemotherapy-Induced Myelosuppression	Chemotherapy-Induced Myelosuppression	Drug:Careseng 1370 Drug:Placebo	详情
437	Study of Anti-CD22 CAR NK Cells in Relapsed and Refractory B Cell Lymphoma	Refractory B-Cell Lymphoma	Biological:Anti-CD22 CAR NK Cells	详情
438	Atorvastatin in Management of Newly Diagnosed ITP	Immune Thrombocytopenia\|Purpura, Thrombocytopenic	Drug:Atorvastatin 20mg Drug:Atorvastatin 10mg	详情
439	[Trial of device that is not approved or cleared by the U.S. FDA]		:	详情
441	Antibiotic Prophylaxis Before Shock Wave Lithotripsy	Ureteral Stones\|Ureteral Calculi\|Nephrolithiasis	Drug:Ciprofloxacin Drug:Placebo	详情
443	Safety and Efficacy of SCT200 in Patients With Relapsed or Metastatic Triple Receptor Negative Breast Cancer	Triple Negative Breast Neoplasms	Biological:SCT200	详情
444	Characteristics of Pts Initiating Spiriva Respimat in Asthma	Asthma	Device:Spiriva Respimat	详情
445	Study of Anti-PSMA CAR NK Cell in Castration-Resistant Prostate Cancer	Castration-resistant Prostate Cancer	Biological:anti-PSMA CAR NK cells	详情

上一页 36 37 38 39 40 41 42 下一页为您找到500条信息